Gilead Sciences
GILD
1,628 hedge funds and large institutions have $116B invested in Gilead Sciences in 2015 Q4 according to their latest regulatory filings, with 157 funds opening new positions, 726 increasing their positions, 581 reducing their positions, and 81 closing their positions.
94% more first-time investments, than exits
New positions opened: 157 | Existing positions closed: 81
25% more repeat investments, than reductions
Existing positions increased: 726 | Existing positions reduced: 581
3% more funds holding
Funds holding: 1,573 → 1,628 (+55)
1% more capital invested
Capital invested by funds: $115B → $116B (+$1.37B)
6% less funds holding in top 10
Funds holding in top 10: 239 → 224 (-15)
22% less call options, than puts
Call options by funds: $2.18B | Put options by funds: $2.79B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
+$435M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$248M |
| 3 |
Renaissance Technologies
New York
|
+$212M |
| 4 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
+$208M |
| 5 |
Morgan Stanley
New York
|
+$168M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$1.76B |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$826M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$313M |
| 4 |
Jennison Associates
New York
|
-$267M |
| 5 |
Edgewood Management
Greenwich,
Connecticut
|
-$242M |
GILD Hedge Fund Activity: Q4 2015 in Review
1,628 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q4 2015, worth a combined $116B — up 1.2% from $115B a quarter earlier.
Buyers outnumbered sellers: 157 funds opened new GILD positions and 81 closed out — a net gain of 76 holders — while 726 added to existing stakes and 581 trimmed.
The largest buyer was BNP Paribas Financial Markets, adding an estimated $435M. The largest seller was Capital Research Global Investors, cutting an estimated $1.76B.
- 1,628 institutional investors held Gilead Sciences (GILD) as of Q4 2015, up from 1,573 in Q3 2015.
- Funds reported $116B of Gilead Sciences stock for Q4 2015, up 1.2% quarter-over-quarter.
- 157 funds opened new Gilead Sciences positions in Q4 2015 and 81 closed out, a net change of +76 holders.
- The largest Gilead Sciences buyer in Q4 2015 was BNP Paribas Financial Markets, an estimated $435M added.
- The largest Gilead Sciences seller in Q4 2015 was Capital Research Global Investors, an estimated $1.76B sold.
Based on aggregated 13F filings for Q4 2015.